Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
A coalition of obesity-related patient advocacy groups is calling on the incoming Trump administration to finalize a proposal ...
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback